|
HS Code |
747126 |
| Product Name | 5-Bromo-2-Methoxypyridine-3-Boronic Acid |
| Cas Number | 1229735-47-6 |
| Molecular Formula | C6H7BBrNO3 |
| Molecular Weight | 231.85 g/mol |
| Appearance | White to off-white solid |
| Purity | Typically ≥ 95% |
| Solubility | Soluble in DMSO, methanol |
| Smiles | COc1ncc(B(O)O)cc1Br |
| Inchi | InChI=1S/C6H7BBrNO3/c1-12-6-4(8)2-5(7(10)11)3-9-6/h2-3,10-11H,1H3 |
| Storage Conditions | Store at 2-8°C, protected from moisture and light |
| Synonyms | 5-Bromo-2-methoxy-3-pyridinylboronic acid |
As an accredited 5-Bromo-2-Methoxypyridine-3-Boronic Acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 5-Bromo-2-Methoxypyridine-3-Boronic Acid prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Synthetic chemistry often feels like weaving a fabric, each thread built with precision. As research chemists and formulation specialists explore new reactions, the value of specialized reagents rises to the surface—for me, one standout has been 5-Bromo-2-Methoxypyridine-3-Boronic Acid. Efforts in pharmaceutical innovation, especially during structure-activity relationship studies, repeatedly return to this compound because of the functional diversity it brings to the lab bench. I’ve watched my colleagues struggle for years when certain substitutions stall a project, but selectively brominated pyridine boronic acids can reinvigorate stalled chemistry with new possibilities.
The molecular formula—C6H7BBrNO3—offers a good snapshot of why this compound matters. With its brominated and methoxylated pyridine core, paired to a boronic acid group, the substance presents as an off-white to pale beige solid at room temperature. Here, it’s not about ticking off technical boxes but recognizing practical stability. In most labs, standard boronic acids can be touchy. They degrade when stored improperly, especially with moisture exposure. 5-Bromo-2-Methoxypyridine-3-Boronic Acid stands out for its shelf resilience. This is owing to the electron-withdrawing bromine, which diminishes unwanted side reactions and oxidation, offering extended usability. When stored in tightly closed containers, protected from direct humidity, chemists notice fewer headaches with shelf degradation.
I’ve worked under tight timelines where boronic acids serve as lynchpins in Suzuki-Miyaura cross-couplings—a method that’s pretty much revolutionized how carbon-carbon bonds get built for drug development, agrochemicals, and advanced materials. The boronic acid group on the pyridine ring bridges electron-rich and electron-deficient partners with less fuss. The 5-bromo group is more than a placeholder; it offers a direct handle for further functionalization. In medicinal chemistry, site-specific bromination saves a lot of headaches downstream—especially for library construction or late-stage diversification.
One of the most valuable aspects is the methoxy group at position 2. It isn’t window dressing. That methoxy, which other pyridine analogs lack, helps modulate the electronic properties of the molecule. In my own reactions, I’ve seen the difference: reactions using 5-bromo-2-methoxypyridine-3-boronic acid generate fewer unmanageable side products, with better overall yields. The electron-donating effect of the methoxy group tempers the reactivity just enough to make selective transformations more likely. That’s a big deal for those aiming at purity in novel compound development.
Chemists have a lot of boronic acids to choose from. So why do they keep coming back to the 5-bromo-2-methoxypyridine-3-boronic acid variety, even at a premium price? From experience—and plenty of late nights troubleshooting reaction mixtures—it comes down to how this specific compound navigates problem spaces that stump other reagents. For one thing, common pyridine boronic acids without bromine can introduce too much nucleophilicity, leading to unwanted byproducts. The bromo group, on the other hand, tempers this by drawing electron density away from the ring, making the molecule more predictable in cross-coupling protocols.
Some people point to 3-bromopyridine-5-boronic acids, or other isomeric variants, as interchangeable options. Yet, selectivity issues keep surfacing. The 2-methoxy substituent in 5-bromo-2-methoxypyridine-3-boronic acid brings a distinct twist; it protects the neighboring ring position from overactivation but keeps the boronic acid available for smooth transmetalation. For those working with heat-sensitive substrates or pursuing routes that involve late-stage functionalizations, this compound provides the right balance between stability and reactivity—making it a go-to when high-value intermediates or API candidates hang in the balance.
In my time working with medicinal chemists optimizing kinase inhibitors, similar heteroaromatic boronic acids were almost always on the request list. The 5-bromo-2-methoxypyridine-3-boronic acid variant steps forward as a favored building block during lead generation and optimization. Its electronic profile helps introduce new vectors for binding-site exploration without extensive reworking of proven scaffolds. A research group I collaborated with leaned on this compound in a novel project developing anti-viral nucleoside analogs. They reported predictable Suzuki couplings, even on large scales—a challenge with more reactive and unstable analogs.
The real excitement comes from how this compound balances adaptability and predictability. In fragment-based drug design, where sticking points with selectivity and off-target activity can derail months of work, the bromo and methoxy substitutions prevent downstream side-reactions. Given how regulatory standards now expect ever-more precise analytical profiles, starting from materials that don’t generate a lot of side impurities slashes both cost and development time.
The value of 5-bromo-2-methoxypyridine-3-boronic acid doesn’t stop at pharmaceuticals. The electronics sector looks for heterocycles that can tune optical or electronic properties in organic semiconductors and OLEDs. The pyridine ring’s nitrogen adds an electron-rich site that can direct charge flow; add in the boronic acid, and polymer chemists gain a powerful option for Suzuki-based chain assembly. The bromine extends this by enabling further elaboration or direct integration into more complex materials with precisely arranged functionalities.
I’ve personally watched synthetic teams use this compound to build block copolymers with selectable photoluminescent properties, the methoxy group playing a subtle but real role in altering electronic absorption. Research findings show a unique balance between rigidity (from the pyridine/bromo motif) and tuneability (from the boronic acid and methoxy). Compared to conventional aryl boronic acids, this molecule’s distinct substitution pattern enables stepwise construction of functionalized polymers destined for optoelectronic interfaces.
Like many specialty reagents, the real challenges show up in sourcing and purity. Counterfeits and inconsistent grade plague niche boronic acids. In practice, cutting corners here introduces headaches that multiply: reaction failures, unreliable analytical data, costly rework. Colleagues tell me that working directly with reputable suppliers—often those engaging in transparent, batch-wise documentation—means less downtime. As someone who’s endured project slowdowns over an impurity spike, robust supply chain traceability and batch consistency have become non-negotiable.
Researchers attempting to substitute cheaper alternatives—say, 5-bromopyridine-3-boronic acid or the unsubstituted parent—often report lower selectivity or extra purification steps. This experience aligns with published studies showing that the combination of bromo and methoxy substituents on the ring achieves an optimal balance of reactivity, stability, and functional group compatibility. In sectors where every hour in R&D translates to major cost implications, minimizing cycle times by using the right tool for the job starts to look less like a splurge and more like best practice.
Working with any boronic acid, especially the halogenated pyridine variants, means taking personal safety seriously. During my lab days, routine use of gloves and working in well-ventilated hoods became standard. Although 5-bromo-2-methoxypyridine-3-boronic acid exhibits solid-state resilience against quick degradation, direct skin and respiratory exposure should stay off the table. Routine training and access to thorough safety data sheets remain important, not just checkboxes in an audit. I have seen experienced colleagues overlook these basics and pay the price with mild dermatitis or irritating coughs that linger. Not only does this slow the bench— it dulls morale.
Importantly, responsible use doesn’t end at the lab bench. Disposal practices—especially for boron- and bromine-bearing wastes—should align with environmental safety standards. My experience in facilities with strong waste management protocols has shown me that careful chemicals disposal avoids regulatory penalties and supports sustainable lab operations. Teams that build a culture around responsible handling and disposal end up ahead, not only in compliance but in reputation.
Chemical innovation wants reliability at every step. Compounds like 5-bromo-2-methoxypyridine-3-boronic acid aren’t flashy in a lineup, but their consistent performance empowers major discoveries. Phase-transfer efficiency, selectivity in coupling, and downstream stability all feed back into quicker, cleaner paths from idea to deliverable. As research foci turn toward high-value targets—cancer therapeutics, green polymers, next-generation electronics—the “small pieces” matter more than ever.
Years of bench work and back-office supply chain conversations have convinced me that short-sighted cost savings on starting materials rarely pay off. The subtle differences—an extra methoxy here, a carefully chosen bromine there—create options that aren’t immediately obvious in raw specs but show their worth in avoided troubleshooting and smoother scale-up.
Emerging fields like molecular electronics and targeted molecular imaging increasingly demand heterocycles tailored for next-level performance. Researchers at major universities highlight 5-bromo-2-methoxypyridine-3-boronic acid as a reliable scaffold when branching into chiral synthesis, advanced peptide labeling, and responsive materials. My own conversations with early-career academic chemists confirm strong demand for this compound whenever a balance of reactivity and selective functionalization shifts a project from interesting to viable.
Open literature reveals a scattering of new catalytic methods that take direct advantage of the 5-bromo-2-methoxypyridine ring. In photoredox catalysis, where uncontrolled side reactivity can shut down imaginative new routes, substituents like these modulate excited-state behavior for more predictable outcomes. The relevance for next-gen organic light-emitting diodes (OLEDs), smart drug delivery, and even polymeric containers for high-tech storage pushes this seemingly modest molecule closer to center stage.
Over years at the bench, I’ve relied on careful pre-reaction analysis to get the best out of specialized boronic acids. 5-bromo-2-methoxypyridine-3-boronic acid rewards close attention. Solubility in common solvents (like dioxane or a THF/water mix) typically lines up with other heteroaryl boronic acids, though the methoxy group can help avoid precipitation during slow additions at scale. Before scaling up a coupling or embarking on fragment elaboration, I’ve made a habit of running rapid small-scale tests. I recommend scouting for unique reactivity quirks: with certain bases or less-common palladium catalysts, subtle differences can make or break conversion rates.
For project managers watching timelines, the ability to step directly from model reactions to multi-gram syntheses with consistent batch-to-batch reliability is not a luxury—it’s essential for meeting targets. My advice, based on supervising teams across academia and industry, is to keep an open dialog between synthetic, analytical, and supply groups, building feedback loops that flag any deviations long before they enter production. When late-stage problems hit, solutions almost always involve circling back to starting materials. With boronic acids, the adage holds: quality in, quality out.
Every year, researchers across pharmaceutical, material, and specialty chemical sectors dig a bit deeper, chasing new targets and faster timelines. It’s compounds like 5-bromo-2-methoxypyridine-3-boronic acid—those that balance reactivity, stability, and precise functional group compatibility—that keep those ambitions grounded in reality. From the bench up, its value shines in its reliability, versatility, and ability to take an experiment from hypothesis to hard data with less trial, less error, and real results.